ABSTRACT
This paper describes a new surgical technique and our clinical experience with video-assisted endoscopic total glandectomy via a middle axillary incision followed by immediate reconstruction with latissimus dorsi muscle flap (LDMF) performed in 17 patients with bigger, multiple tumors or extensive ductal spread of breast cancer. The novel techniques in this procedure are as follows: (1) By securing patients in a semi-lateral position and suspending the upper extremity, either supine or semi-lateral position can be easily achieved by simply rotating the operating table, resulting in a wider working space from the axillary to hip area. (2) By applying a retractor for skin flap traction, endoscopic glandectomy and reconstruction become safe and reliable. As a result, the mean number and size of tumors were 1.2 and 4.12 cm, respectively. Surgical margins of all the cases were pathologically negative and there were no recurrences observed during 14 months follow-up to date. Esthetic results have been satisfactory and the surgical wounds were not visible from the front in any case. Compared to mastectomy, this procedure shows the same therapeutic results, but offers a greater esthetic and psychological advantage to all the patients.
Subject(s)
Breast Neoplasms/surgery , Lymph Node Excision/methods , Mammaplasty/methods , Video-Assisted Surgery/methods , Breast Neoplasms/pathology , Endoscopy/methods , Endoscopy/statistics & numerical data , Female , Follow-Up Studies , Humans , Lymph Node Excision/instrumentation , Lymph Node Excision/statistics & numerical data , Mammaplasty/instrumentation , Mammaplasty/statistics & numerical data , Middle Aged , Video-Assisted Surgery/instrumentation , Video-Assisted Surgery/statistics & numerical dataABSTRACT
Breast conservation surgery has become a standard operation as a minimally invasive surgery for breast cancer in Japan. Now sentinel lymph node biopsy (SLNB), day surgery, and endoscopy assisted surgery are being introduced as more minimally invasive surgeries for breast cancer. When blue dye and/or isotope are injected into the peri-tumoral breast gland, the sentinel lymph nodes (SLN) can be detected easily, and node negative patients can be selected with certainty. When no metastasis is found in SLN by frozen section, T1N0 breast cancer patients can be treated without lymph node dissection. Using this technique, day surgery for patients who have clinically node-negative small breast cancer (less than 1.5 cm in diameter) is performed under local anesthesia. We have developed an endoscopy assisted conservation surgery for breast cancer. Using endoscopy, partial or total glandectomy with radical axillary lymph node dissection is performed via a 5 cm skin incision on the middle axillary line. When the amount of glandectomy is over one third, we perform immediate reconstruction using the latissimus dorsi. These minimally invasive surgeries for breast cancer will result in a better quality of life for breast cancer patients.
Subject(s)
Breast Neoplasms/surgery , Mastectomy, Segmental/methods , Minimally Invasive Surgical Procedures/methods , Adult , Aged , Ambulatory Surgical Procedures , Breast Neoplasms/pathology , Female , Humans , Lymph Node Excision , Lymphatic Metastasis , Middle Aged , Sentinel Lymph Node Biopsy/methodsABSTRACT
To determine the possible contribution of apoptosis in the pathogenesis of acute lung injury (ALI), we investigated Fas antigen (Fas), Fas ligand (FasL), perforin, granzyme A, and granzyme B expressions in a murine model of ALI after intratracheal instillation of Escherichia coli lipopolysaccharide (LPS: 0.3-30 microg) into the left lung. Lung injury, examined by water-to-dry weight ratio and albumin leakage, demonstrated maximal epithelial injury 1 d after 30 microg LPS instillation. Expressions of the proapoptosis molecules' mRNA were dose-dependently up-regulated, with maximal expression in the early phase in the instilled lung and most apparent 1 d after LPS instillation. Negligible mRNA expression of proapoptosis molecules was observed in noninstilled lungs. The terminal deoxynucleotidyl transferase-mediated dUTP biotin nick end labeling (TUNEL) demonstrated positive signals in neutrophils and macrophages as well as in alveolar wall cells of the instilled lung 1 d after LPS instillation. Immunohistochemistry demonstrated that Fas was up-regulated in alveolar and inflammatory cells and FasL-positive inflammatory cells migrated into the air spaces in the LPS-instilled lung. Intratracheal administration of P2 antibody, which is an anti-Fas blocking antibody, attenuated the lung injury after 30 microg LPS instillation without attenuating mRNA expressions of proapoptosis molecules and neutrophil accumulation in the lung. In contrast, concanamycin A, which inhibits the function of perforin, did not alter the outcome after LPS instillation. These results indicate that the Fas/FasL system could be important in the pathogenesis of LPS-induced ALI, and proper regulation of the FasL/Fas system might be important for potential treatment of ARDS.
Subject(s)
Antigens, Surface/physiology , Apoptosis , Immunoglobulins/physiology , Membrane Glycoproteins/physiology , Neuropeptides/physiology , Pulmonary Alveoli/pathology , Receptors, Tumor Necrosis Factor , Respiratory Distress Syndrome/pathology , Animals , Fas Ligand Protein , Lipopolysaccharides/administration & dosage , Male , Mice , Mice, Inbred ICR , Respiratory Distress Syndrome/chemically induced , fas ReceptorABSTRACT
E2F is a family of transcription factors which regulates cell cycle and apoptosis of mammalian cells. E2F-1-3 localize in the nucleus, and preferentially bind pRb, while E2F-4 and 5 have no nuclear localization signal and preferentially bind p107/p130. E2F-6 suppresses the transcriptional activity of other E2F proteins. DP-1 and 2 are heterodimeric partners of each E2F protein. Using tetracycline-responsive promoters, here we compared the effects of ectopic expression of E2F-1, DP-1 and E2F-4 on cell cycle progression and apoptosis in Chinese hamster cell lines. We found that E2F-4, as well as DP-1 and E2F-1, induced growth arrest and caspase-dependent apoptosis. E2F-4 did not have a marked effect on cell cycle progression, while E2F-1 induced DNA synthesis of resting cells and DP-1 arrested cells in G1. Ectopic expression of E2F-4 did not activate E2F-dependent transcription. Our results suggest that expression of E2F-4 at elevated levels induces growth arrest and apoptosis of mammalian cells through a mechanism distinct from E2F-1 and DP-1.
Subject(s)
Apoptosis/physiology , Carrier Proteins , Caspases/physiology , Cell Cycle Proteins , DNA-Binding Proteins/physiology , Transcription Factors/physiology , Animals , CHO Cells , Cell Cycle/physiology , Cricetinae , Cricetulus , DNA Replication/physiology , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/genetics , E2F Transcription Factors , E2F1 Transcription Factor , E2F4 Transcription Factor , E2F6 Transcription Factor , Gene Expression Regulation/drug effects , Promoter Regions, Genetic , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/physiology , Retinoblastoma-Binding Protein 1 , Tetracycline/pharmacology , Transcription Factors/biosynthesis , Transcription Factors/genetics , Transcriptional Activation , TransfectionSubject(s)
Antibody-Dependent Cell Cytotoxicity , Caspases/metabolism , Serine Endopeptidases/metabolism , Transplantation, Heterologous/immunology , Animals , Antibody-Dependent Cell Cytotoxicity/drug effects , Cell Line , Granzymes , Humans , Kidney , Serine Proteinase Inhibitors/pharmacology , SwineSubject(s)
Antibody-Dependent Cell Cytotoxicity , Apoptosis/immunology , Genes, bcl-2 , Membrane Glycoproteins/immunology , Proto-Oncogene Proteins c-bcl-2/metabolism , Serine Endopeptidases/metabolism , fas Receptor/immunology , Animals , Antibodies, Heterophile/immunology , Cell Line , Fas Ligand Protein , Humans , Kidney , Mice , Perforin , Pore Forming Cytotoxic Proteins , Swine , T-Lymphocytes, Cytotoxic/immunology , TransfectionABSTRACT
A bacterium, strain NM 5-3, isolated from soil exhibited the highest cyclo(Gly-Leu) (CGL)-hydrolyzing activity and was identified as Agrobacterium radiobacter. The reaction products from CGL were dipeptides (Leu-Gly and Gly-Leu) and amino acids (Leu and Gly). Inhibitors for the dipeptidase of this strain did not inhibit the hydrolysis of CGL to dipeptides, indicating that two distinct enzymes, CGLase and a dipeptidase, were involved in its hydrolysis. The activities of these two enzymes were separated by anion-exchange column chromatography. The results indicated that strain NM5-3 hydrolyzed CGL via the dipeptides to the corresponding amino acids. The CGLase fraction was found to catalyze the hydrolysis of cyclo(Gly-D-Leu), cyclo(Gly-Gly), cyclo(L-Ala-Gly), and cyclo(D-Ala-Gly). On the other hand, the dipeptidase fraction exhibited L-specific substrate specificity.
Subject(s)
Antibody-Dependent Cell Cytotoxicity , Membrane Glycoproteins/immunology , Transplantation, Heterologous/immunology , Animals , Cells, Cultured , Fas Ligand Protein , Gene Expression Regulation/immunology , Humans , Interleukin-2/pharmacology , Killer Cells, Lymphokine-Activated/immunology , Membrane Glycoproteins/genetics , Metalloendopeptidases/antagonists & inhibitors , Protease Inhibitors/pharmacology , Recombinant Proteins/immunology , Swine , TransfectionSubject(s)
Graft Survival/drug effects , Heart Transplantation/immunology , Immunosuppressive Agents/therapeutic use , Propylene Glycols/therapeutic use , Transplantation, Heterologous/immunology , Animals , Antibodies, Heterophile/blood , Combined Modality Therapy , Cricetinae , Fingolimod Hydrochloride , Graft Survival/immunology , Guanidines/therapeutic use , Heart Transplantation/pathology , Immunosuppression Therapy/methods , Lymphocyte Culture Test, Mixed , Rats , Rats, Inbred Lew , Sphingosine/analogs & derivatives , Spleen/immunology , Splenectomy , Transplantation, Heterologous/pathologySubject(s)
Hepatitis B Antibodies/blood , Hepatitis B Surface Antigens/blood , Kidney Transplantation , Living Donors , Adult , Female , Hepacivirus/isolation & purification , Hepatitis C/transmission , Humans , Kidney Transplantation/physiology , Male , Middle Aged , Polymerase Chain Reaction , RNA, Viral/genetics , RNA, Viral/isolation & purificationSubject(s)
Hyperinsulinism/prevention & control , Pancreas Transplantation , Thiazolidinediones , Animals , Chromans/therapeutic use , Hypoglycemic Agents/therapeutic use , Male , Portal System/surgery , Postoperative Complications/prevention & control , Rats , Rats, Inbred Lew , Thiazoles/therapeutic use , TroglitazoneABSTRACT
In order to clarify the role of natural killer (NK) cells in delayed xenograft rejection (DXR) of discordant xenotransplantation, we used in vitro xenogeneic combination of human NK cells and pig kidney target cells (PK15), and investigated the mechanism of xenogeneic cytotoxicity caused by human NK cells. In the presence of decomplemented human serum or human IgG, freshly isolated human peripheral blood lymphocytes (PBLs) caused both membrane (51Cr release) and DNA (3H release) damage on PK15. In contrast, only membrane damage was detected in the presence of normal human serum. To clarify the participation of perforin/granzymescell mediated cytotoxicity (P/G-CMC), when EGTA or concanamycin B (CMB) was added to the cytotoxicity assays, both cytotoxicities were completely inhibited by these drugs in a dose-dependent manner. In terms of the involvement of Fas/FasL-based cytotoxicity (F-CMC), while the cytotoxicity assays were performed in the presence of antagonistic anti-human FasL mAb, this antibody was not able to block the cytotoxicity. From these results, it is concluded that xenogeneic cytotoxicity is due to NK cell dependent ADCC (antibody-dependent cell-mediated cytotoxicity), and their effector mechanism can cause apoptosis on target cells via P/G-CMC.
Subject(s)
Apoptosis/immunology , Cytotoxicity, Immunologic , Transplantation, Heterologous/adverse effects , Transplantation, Heterologous/immunology , Animals , Antibody-Dependent Cell Cytotoxicity , Cell Line , Fas Ligand Protein , Graft Rejection/etiology , Graft Rejection/immunology , Humans , In Vitro Techniques , Killer Cells, Natural/immunology , Membrane Glycoproteins/metabolism , Perforin , Pore Forming Cytotoxic Proteins , Swine , fas Receptor/metabolismSubject(s)
Graft Survival/physiology , Heart Transplantation/physiology , Immunosuppressive Agents/therapeutic use , Membrane Glycoproteins/genetics , Propylene Glycols/therapeutic use , Serine Endopeptidases/genetics , Transcription, Genetic/drug effects , Animals , DNA Primers , Fingolimod Hydrochloride , Graft Survival/drug effects , Granzymes , Heart Transplantation/immunology , Immunosuppressive Agents/pharmacology , Perforin , Polymerase Chain Reaction , Pore Forming Cytotoxic Proteins , Propylene Glycols/pharmacology , RNA, Messenger/genetics , Rats , Rats, Inbred BN , Rats, Inbred Lew , Sphingosine/analogs & derivatives , T-Lymphocytes, Cytotoxic/immunology , Transplantation, HomologousSubject(s)
Apoptosis/physiology , Caspases , Cysteine Endopeptidases/metabolism , Immunosuppressive Agents/pharmacology , Lymphoma/immunology , Propylene Glycols/pharmacology , Animals , Apoptosis/drug effects , Caspase 1 , Caspase 2 , Cell Nucleus/drug effects , Cell Nucleus/pathology , Dose-Response Relationship, Drug , Enzyme Activation , Fingolimod Hydrochloride , Kinetics , Lymphoma/enzymology , Lymphoma/pathology , Mice , Proteins/metabolism , Sphingosine/analogs & derivatives , Tumor Cells, CulturedSubject(s)
Antibody-Dependent Cell Cytotoxicity , Lymphocytes/immunology , Membrane Glycoproteins/physiology , Transplantation, Heterologous/immunology , fas Receptor/physiology , Animals , Antigens, Heterophile/immunology , Apoptosis , Clone Cells , DNA Damage , Fas Ligand Protein , Humans , Membrane Glycoproteins/genetics , Mice , Recombinant Proteins/biosynthesis , Swine , Transfection , fas Receptor/geneticsABSTRACT
A 64-year-old female who was diagnosed with an amylase-producing tumor of unknown origin was treated by hyperthermochemotherapy. The patient was admitted with a complaint of abdominal fullness due to ascites. Laboratory examination showed high levels of serum amylase and tumor markers, including CA15-3, CA 125 and CA 72-4. Laparotomy showed peritoneal dissemination with histological findings of adenocarcinoma of unknown origin. After laparotomy, she was given hyperthermia combined with chemotherapy using carboplatin (CBDCA), mitomycin C (MMC) and doxifluridine (5'-DFUR). Hyperthermia (13.56 MHz radiofrequency for 40-50 min) was performed a total of six times within one and a half months. The total doses of CBDCA and MMC were 450 mg and 24 mg, respectively, and 600 mg of 5'-DFUR was orally administered every day. By these combined treatments, ascites disappeared and serum levels of amylase and all tumor markers were decreased and normalized. MRI and echo examination also showed complete disappearance of peritoneal metastasis. Two and a half years after the treatment, the patient is alive without any evidence of recurrence, which suggests that this combined therapy is one of the useful modalities for peritoneal dissemination as well as an inoperable tumor itself.